This study aims to systematically investigate the molecular mechanisms underlying VPS37A downregulation in driving malignant phenotypic manifestations in CRC, with a dedicated emphasis on delineating how its dysregulation modulates cell death signaling cascades through molecular intermediaries. The gene discussed is VPS37A; the disease is colorectal carcinoma.